Scientists have found an experimental small molecule that induces a form of cell death to kill a variety of cancers while enhancing the power of the immune system and leaving healthy cells totally unscathed.
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, ...
Aug 23, 2023
0
44
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
Injections of an engineered antibody known as AMY109, given every month, were found to reduce lesion volume and lessen scar tissue and organ adhesions in monkeys with endometriosis.
A team of researchers affiliated with several entities in Thailand, working with two colleagues from the U.S. and two from Canada, has developed a mRNA COVID-19 vaccine that can be safely refrigerated for up to three months ...
An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...
Nov 3, 2022
0
2102
When Marie Antoinette was captured during the French Revolution, her hair reportedly turned white overnight. In more recent history, John McCain experienced severe injuries as a prisoner of war during the Vietnam War—and ...
Jan 22, 2020
1
1659
Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds ...
Oct 9, 2013
0
1
New research suggests psilocybin has similar side effects to traditional antidepressants. Commonly referred to as "magic mushrooms," psilocybin is a promising alternative treatment for people with medication-resistant depression ...
16 hours ago
0
54
Researchers at the Indian Institute of Science (IISc) have designed a synthetic compound (antigen) that can latch on to a protein in blood and hitchhike a ride to the lymph node, where it can boost the production of antibodies ...
Apr 22, 2024
0
15
